GAO: FDA Should Strengthen Policies Guiding Audits of Third-Party Review Organizations

The Government Accountability Office has recommended that the FDA strengthen its policies for auditing third-party review organizations involved in medical device evaluation. This addresses regulatory oversight and quality assurance in device review processes.